pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
637
stories
12d
STAT+: Nominee to lead FDA aims to speed up medical research, combat China’s rise
stat
12d
STAT+: FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks
stat
12d
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
biospace
12d
STAT+: UnitedHealth, CVS push back on Medicare plan to curb remote patient monitoring
stat
12d
9 companies hiring in Pennsylvania now
biospace
13d
Amgen reports a Phase 3 win with Sjögren’s drug candidate
biopharma dive
13d
Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030
biospace
13d
STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program
stat
13d
2026 IPO blitz continues with 4 new biotech filings
biospace
13d
Novo’s workforce reduction climbs to 13,000 to fuel R&D work
biospace
13d
Roche’s Carmot asset normalizes blood sugar, cuts weight in Phase 2 diabetes trial
biospace
13d
STAT+: Pharmalittle: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and more
stat
13d
Celldex monoclonal antibody rebounds with pair of phase 3 wins for chronic skin condition
fiercebiotech
13d
Lexeo takes up the Mantle in $8M acquisition for Friedreich ataxia assets
fiercebiotech
13d
Siemens Healthineers and Novo team up on fatty liver disease awareness, testing
fiercebiotech
14d
Anaconda Biomed snares $56M in funding for endovascular tech
fiercebiotech
14d
Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes
fiercebiotech
14d
STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators
stat
14d
Novo’s plan to hit $23B in revenue by 2035 leaves investors wanting
biospace
14d
President Trump’s newest vaccine ‘demands’ repeat old misinformation
stat
14d
Novo struggles to appease restive investors with consumer plans, blockbuster ambitions
fiercebiotech
14d
Behind the outcomes: How whole-patient support is reshaping oncology care
biopharma dive
14d
Are healthcare systems really ready for GLP-1s?
biopharma dive
14d
Skeptical about modern medicine? I know the feeling — and want to listen
stat
15d
Retension and Lilly-backed TRex Bio both set out plans to join biotech IPO stampede
fiercebiotech
16d
Jehovah’s Witnesses allow blood-derived products but keep ban on whole-blood transfusions
stat
17d
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
fda recalls
17d
Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
biopharma dive
17d
Opinion: Doctors should educate patients about ‘Asian glow’ and drinking risks
stat
18d
BMS dumps $100M Orum degrader-antibody conjugate after glimpsing phase 1 data
fiercebiotech
← prev
page 3 of 22
next →
